David Wallace, MD, MPH, serves as chair for the IU School of Medicine Department of Ophthalmology and director of the Eugene and Marilyn Glick Eye Institute. A native Hoosier and IU School of Medicine alumnus, Dr. Wallace joined the department from Duke University where he served as a professor of ophthalmology and pediatrics, vice chair for clinical strategic planning and director for clinical research. Prior to joining the faculty at Duke, Dr. Wallace served as the ophthalmology residency program director at the University of North Carolina for six years where he also obtained a master's degree in public health in epidemiology.
Dr. Wallace's primary research interests are retinopathy of prematurity (ROP), amblyopia and clinical trials. He served a five-year term as chair of the Pediatric Eye Disease Investigator Group (PEDIG), a National Institutes of Health-funded, national clinical research network, and he currently leads a multicenter, phase 1 dose-finding study of bevacizumab for ROP.
Dr. Wallace has lectured internationally and has authored or co-authored more than 140 scientific publications. He has served as senior associate editor for the Journal of the American Association of Pediatric Ophthalmology and Strabismus, and as president of the North Carolina Society of Eye Physicians and Surgeons. Read more about Dr. Wallace in this Q&A.